Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

LI KANG BIOMEDICAL Co. Ltd. (6242) Financial Statements

LI KANG BIOMEDICAL Co. Ltd. Financial Overview

LI KANG BIOMEDICAL Co. Ltd.'s market cap is currently NT$1.07B. The company's EPS TTM is NT$2.41; its P/E ratio is 13.90; and it has a dividend yield of 5.97%. LI KANG BIOMEDICAL Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 589.21MNT$ 565.51MNT$ 629.38MNT$ 684.25MNT$ 386.97M
Gross ProfitNT$ 398.25MNT$ 386.10MNT$ 426.14MNT$ 388.58MNT$ 264.68M
Operating IncomeNT$ 98.28MNT$ 90.02MNT$ 133.37MNT$ 137.36MNT$ 63.94M
EBITDANT$ 113.22MNT$ 112.16MNT$ 151.37MNT$ 152.07MNT$ 76.83M
Net IncomeNT$ 83.82MNT$ 77.02MNT$ 110.99MNT$ 112.09MNT$ 51.44M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 190.22MNT$ 454.40MNT$ 301.02MNT$ 263.43MNT$ 175.75M
Total AssetsNT$ 1.09BNT$ 1.04BNT$ 827.00MNT$ 688.84MNT$ 616.07M
Total DebtNT$ 148.39MNT$ 105.91MNT$ 101.44MNT$ 18.55MNT$ 41.34M
Net DebtNT$ 105.46MNT$ 40.96MNT$ -10.40MNT$ -113.46MNT$ -60.02M
Total LiabilitiesNT$ 221.82MNT$ 179.93MNT$ 196.97MNT$ 118.70MNT$ 124.07M
Stockholders' EquityNT$ 871.24MNT$ 855.68MNT$ 630.03MNT$ 570.14MNT$ 492.00M
Cash Flow
Free Cash FlowNT$ -240.94MNT$ 654.00KNT$ 93.48MNT$ 154.54MNT$ 56.00M
Operating Cash FlowNT$ 88.44MNT$ 65.38MNT$ 96.74MNT$ 157.24MNT$ 60.45M
Investing Cash FlowNT$ -88.24MNT$ -257.76MNT$ -61.84MNT$ -59.62MNT$ 12.20M
Financing Cash FlowNT$ -22.22MNT$ 145.48MNT$ -55.07MNT$ -66.97MNT$ -69.39M

Currency in TWD

LI KANG BIOMEDICAL Co. Ltd. Earnings and Revenue History

0250M500M750M12 %14 %16 %18 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

LI KANG BIOMEDICAL Co. Ltd. Liabilities to Assets

0400M800M1.2B16 %20 %24 %28 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

LI KANG BIOMEDICAL Co. Ltd. Cash Flow

-300M-200M-100M0100M200M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

LI KANG BIOMEDICAL Co. Ltd. Forecast EPS vs Actual EPS

0.20.40.60.81Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >